Karo Pharma AB (publ)
KARBF News Today: Stay Updated with the Latest Karo Pharma AB (publ) News in Real Time
Find KARBF news now at Meyka AI. Stay informed with the latest Karo Pharma AB (publ) stocks updates, including price news, market analysis, and expert insights.
0503.HK Lansen Pharma HKSE +40.94% pre-market 27 Mar 2026: outlook
Pre-market high-volume mover: 0503.HK stock jumps to HKD 1.79 on heavy volume; short-term outlook and Meyka AI forecast
IPH.PA Innate Pharma (EURONEXT): 55% revenue drop before 26 Mar 2026 results, runway risk
Intraday earnings spotlight on IPH.PA stock: Q4 sales -55% and cash runway update for 26 Mar 2026
Cowen Maintains AZN (AstraZeneca PLC) at Buy on March 18, 2026
Cowen maintains AZN at Buy on March 18, 2026; AZN analyst rating remains positive with Meyka grade A
VOW3.DE Stock Today, March 25: VW Mulls Osnabrueck Air-Defense Shift
Volkswagen missile defense talks with Rafael could shift work to the Osnabrueck plant. We assess what this means for Swiss investors, Volkswagen stock levels, valuation, and key catalysts today.
Merck to buy Terns (TERN) NASDAQ for $53 on 25 Mar 2026: earnings catalyst for TERN stock
Merck offer lifts TERN stock as earnings loom 25 Mar 2026; Meyka AI forecast and intraday outlook for investors
Merck Close to $6 Billion Deal to Acquire Terns Pharma, FT Says
Global pharmaceutical giant Merck is reportedly nearing a major acquisition worth nearly $6 billion, according to a Financial Times report. The deal involves U.S.-based biotech company Terns Pharmaceuticals and reflects a broader shift in the healthcare industry as large drugmakers race to strengthen their future drug pipelines. The potential acquisition has already sparked strong reactions…
Sai Parenteral IPO Update: Day 2 Demand, GMP Trends & Investment Outlook
The initial public offering (IPO) of Sai Parenteral Limited has grabbed headlines as it entered Day 2 of bidding on March 25, 2026, with investors watching closely. The ₹409 crore issue opened on March 24 with a price band of ₹372–₹392 per share. Early subscription figures have been underwhelming, and the grey market premium (GMP) remains flat at ₹0, hinting…
US Attorney for New Jersey Shake-Up Ends DOJ Standoff — March 25
Robert Frazer named acting United States Attorney for the District of New Jersey, ending a New Jersey DOJ standoff. What this means for Canadian investors in healthcare, pharma, and finance.
Phase 3 lifts outlook: MaaT Pharma MAAT.PA Euronext pre-market Mar 2026 earnings
MAAT.PA stock update: Phase-3 results reshape pre-market outlook ahead of 30 Mar earnings, model projects monthly €6.94